2021 Q4 Form 10-Q Financial Statement
#000114036121037756 Filed on November 15, 2021
Income Statement
Concept | 2021 Q4 | 2021 Q3 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $1.569M | $1.631M |
YoY Change | 7.47% | 41.83% |
% of Gross Profit | ||
Research & Development | $5.856M | $6.613M |
YoY Change | -8.07% | 38.35% |
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $7.425M | $8.244M |
YoY Change | -5.17% | 39.02% |
Operating Profit | -$8.244M | |
YoY Change | ||
Interest Expense | $204.0K | -$276.0K |
YoY Change | -1120.0% | 1280.0% |
% of Operating Profit | ||
Other Income/Expense, Net | -$276.0K | |
YoY Change | ||
Pretax Income | -$7.221M | -$8.520M |
YoY Change | -8.01% | 43.43% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | -$7.221M | -$8.520M |
YoY Change | -8.01% | 43.43% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | -$0.14 | |
Diluted Earnings Per Share | -$121.7K | -$143.7K |
COMMON SHARES | ||
Basic Shares Outstanding | 59.34M | 59.29M |
Diluted Shares Outstanding | 59.29M |
Balance Sheet
Concept | 2021 Q4 | 2021 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $39.65M | $36.60M |
YoY Change | 46.09% | 12.41% |
Cash & Equivalents | $39.65M | $36.60M |
Short-Term Investments | ||
Other Short-Term Assets | $2.172M | $1.398M |
YoY Change | -6.38% | 5.11% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $41.82M | $38.00M |
YoY Change | 41.93% | 12.15% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $0.00 | $18.00K |
YoY Change | -70.0% | |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $7.000K | $22.00K |
YoY Change | -94.81% | -80.0% |
Total Long-Term Assets | $7.000K | $40.00K |
YoY Change | -94.81% | -76.47% |
TOTAL ASSETS | ||
Total Short-Term Assets | $41.82M | $38.00M |
Total Long-Term Assets | $7.000K | $40.00K |
Total Assets | $41.83M | $38.04M |
YoY Change | 41.31% | 11.71% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.805M | $1.917M |
YoY Change | 39.71% | 177.83% |
Accrued Expenses | $7.163M | $6.382M |
YoY Change | 77.21% | 254.56% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $9.033M | $8.299M |
YoY Change | 67.31% | 233.29% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $29.05M | $19.30M |
YoY Change | ||
Other Long-Term Liabilities | $0.00 | $1.191M |
YoY Change | -100.0% | 5855.0% |
Total Long-Term Liabilities | $0.00 | $20.49M |
YoY Change | -100.0% | 102350.0% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $9.033M | $8.299M |
Total Long-Term Liabilities | $0.00 | $20.49M |
Total Liabilities | $39.21M | $28.79M |
YoY Change | 625.19% | 1046.97% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$270.7M | |
YoY Change | 12.79% | |
Common Stock | $59.00K | |
YoY Change | 5.36% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $893.0K | $9.249M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $41.83M | $38.04M |
YoY Change | 41.31% | 11.71% |
Cashflow Statement
Concept | 2021 Q4 | 2021 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$7.221M | -$8.520M |
YoY Change | -8.01% | 43.43% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$6.951M | -$4.998M |
YoY Change | 28.48% | -39.12% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 9.999M | 10.00M |
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | -6.951M | -4.998M |
Cash From Investing Activities | ||
Cash From Financing Activities | 9.999M | 10.00M |
Net Change In Cash | 3.048M | 5.002M |
YoY Change | -156.34% | -160.93% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$6.951M | -$4.998M |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Amendment Flag
AmendmentFlag
|
false | ||
CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1302500 | |
CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1302500 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1302500 | |
CY2021Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1302500 | |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001133416 | ||
CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent | |
CY2021Q3 | us-gaap |
Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
|
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2021-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-31791 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
GALECTIN THERAPEUTICS INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
04-3562325 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4960 Peachtree Industrial Blvd. | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 240 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Norcross | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
GA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
30071 | ||
dei |
City Area Code
CityAreaCode
|
678 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
620 -3186 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
GALT | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2021Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
59341305 | |
CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q3 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-166000 | |
CY2020Q3 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | |
us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
-338000 | ||
us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | ||
CY2021Q3 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
37000 | |
CY2020Q3 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
12000 | |
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
104000 | ||
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
72000 | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
20000000 | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | ||
us-gaap |
Stock Issued1
StockIssued1
|
104000 | ||
us-gaap |
Stock Issued1
StockIssued1
|
137000 | ||
galt |
Fair Value Of Derivative Related To Related Party Convertible Note Payable
FairValueOfDerivativeRelatedToRelatedPartyConvertibleNotePayable
|
853000 | ||
galt |
Fair Value Of Derivative Related To Related Party Convertible Note Payable
FairValueOfDerivativeRelatedToRelatedPartyConvertibleNotePayable
|
0 | ||
galt |
Reclassification Of Accrued Bonus To Additional Paid In Capital
ReclassificationOfAccruedBonusToAdditionalPaidInCapital
|
60000 | ||
galt |
Reclassification Of Accrued Bonus To Additional Paid In Capital
ReclassificationOfAccruedBonusToAdditionalPaidInCapital
|
0 | ||
galt |
Convertible Preferred Stock Dividends
ConvertiblePreferredStockDividends
|
39000 | ||
galt |
Temporary Equity Dividends
TemporaryEquityDividends
|
-26000 | ||
galt |
Stock Issued During Period Value Warrants And Options Exercised
StockIssuedDuringPeriodValueWarrantsAndOptionsExercised
|
219000 | ||
galt |
Convertible Preferred Stock Dividends
ConvertiblePreferredStockDividends
|
38000 | ||
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3864000 | ||
galt |
Stock Issued During Period Value Warrants And Options Exercised
StockIssuedDuringPeriodValueWarrantsAndOptionsExercised
|
2951000 | ||
CY2021Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
10000000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
36600000 | |
CY2020Q4 | galt |
Accrued Research And Development Costs And Other Current
AccruedResearchAndDevelopmentCostsAndOtherCurrent
|
3087000 | |
CY2021Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
127000 | |
CY2021Q3 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
3346200000 | |
CY2021Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
2401668 | |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.71 | ||
CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
19000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
44000 | |
CY2021Q3 | galt |
Accrued Research And Development Costs And Other Current
AccruedResearchAndDevelopmentCostsAndOtherCurrent
|
5716000 | |
CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
122000 | |
CY2021Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
520000 | |
CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
789000 | |
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6382000 | |
CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4042000 | |
CY2019Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
10000000 | |
CY2019Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
500000 | |
CY2019Q2 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2500000 | |
CY2021Q3 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
0 | |
CY2019Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
500000 | |
CY2021Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
696000 | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
65000 | ||
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
65000 | ||
CY2021Q3 | us-gaap |
Line Of Credit
LineOfCredit
|
0 | |
CY2021Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
587000 | |
CY2020Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
408000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1422000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1232000 | ||
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3987575 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.29 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2260000 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.31 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
396664 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.35 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
1190350 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.18 | ||
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4660561 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.27 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2260000 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
396664 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0058 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0126 | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.91 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.98 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
CY2021Q3 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P3Y | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
19800825 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
17036203 | ||
galt |
Contract Cancelation Notice Period
ContractCancelationNoticePeriod
|
P30D | ||
galt |
Number Of Operating Leases
NumberOfOperatingLeases
|
1 | ||
CY2021Q3 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P38M | |
galt |
Free Rent Period
FreeRentPeriod
|
P2M | ||
CY2021Q3 | us-gaap |
Security Deposit
SecurityDeposit
|
6000 | |
CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
18000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
19000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
12000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
8000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
20000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
1000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
19000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.1104 |